Trials / Completed
CompletedNCT01580644
Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers
Bioavailability Study of Two Formulations of the Isopropyl Malonate Prodrug of GLPG0187 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Galapagos NV · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the amount of GLPG0187 present in the blood (pharmacokinetics) after a single oral dose of the prodrug of GLPG0187 given to healthy subjects. Two formulations of the GLPG0187 prodrug will be compared, as well as the effect of food and dose proportionality of the best formulation. Furthermore, during the course of the study, safety and tolerability will be characterized.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLPG0187 prodrug |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2012-04-19
- Last updated
- 2012-04-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01580644. Inclusion in this directory is not an endorsement.